440 related articles for article (PubMed ID: 5340335)
21. [Management of lymphoma with respect to pathologic classification: updates and controversies].
Zhu J; Song YQ
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009
[No Abstract] [Full Text] [Related]
22. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.
Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B
Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882
[No Abstract] [Full Text] [Related]
23. Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
Bennett JM; Bakemeier RF; Carbone PP; Ezdinli E; Lenhard RE
Cancer Treat Rep; 1976 Jun; 60(6):739-45. PubMed ID: 60176
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of reticulosarcomas and lymphosarcomas. A 10-year analysis].
Chauvergne J; Hoerni-Simon G; Durand M; Meuge C; Goerni B
Bull Cancer; 1974; 61(1):119-28. PubMed ID: 4142404
[No Abstract] [Full Text] [Related]
25. Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma.
Stutzman L; Ezdinli EZ; Stutzman MA
JAMA; 1966 Jan; 195(3):173-8. PubMed ID: 5322863
[No Abstract] [Full Text] [Related]
26. Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Bishop RC
Radiol Clin North Am; 1968 Apr; 6(1):91-5. PubMed ID: 5652936
[No Abstract] [Full Text] [Related]
27. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
28. [Experience with vinblastine in the treatment of lymphoblastomas].
Capretti G
Cancro; 1968; 21():Suppl 6:93-7. PubMed ID: 4906146
[No Abstract] [Full Text] [Related]
29. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
30. [Response and survival after sequential monochemotherapy in malignant lymphocytic and histocytic lymphoma].
Monfardini S; Tancini G; Gasparini M; Pizzetti F; De Lena M; Bonadonna G
Tumori; 1973; 59(3):219-38. PubMed ID: 4580942
[No Abstract] [Full Text] [Related]
31. Non-Hodgkin's lymphomas. II. Single agent chemotherapy.
Jones SE; Rosenberg SA; Kaplan HS; Kadin ME; Dorfman RF
Cancer; 1972 Jul; 30(1):31-8. PubMed ID: 4557278
[No Abstract] [Full Text] [Related]
32. Use of vinblastine for maintenance therapy in malignant lymphomas.
Klener P; Donner L; Ort J
Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
[No Abstract] [Full Text] [Related]
33. [Chemotherapy in the terminal stages of tumors].
Astrakhan VI; Garin AM; Vvedenskaia NA; Bychkov MB
Vopr Onkol; 1968; 14(6):92-6. PubMed ID: 4881119
[No Abstract] [Full Text] [Related]
34. Combined radiotherapy and chemotherapy of lymphomas and other cancers.
Stutzman L
Cancer Res; 1971 Nov; 31(11):1845-50. PubMed ID: 4941353
[No Abstract] [Full Text] [Related]
35. [Simultaneous radio- and chemotherapy in pediatric oncology].
Wagner HP
Radiol Clin Biol; 1972; 41(4):274-84. PubMed ID: 4560702
[No Abstract] [Full Text] [Related]
36. The therapy of lymphoma.
Ultmann JE; Nixon DD
Semin Hematol; 1969 Oct; 6(4):376-403. PubMed ID: 4900653
[No Abstract] [Full Text] [Related]
37. [Therapy of non-Hodgkin lymphomas with COP and COPP regimens (author's transl)].
Rubio-Félix D; Maicas M; Rubio-Vitaller A; Gil JL; Giralt M; Raichs A
Sangre (Barc); 1977; 22(5B):854-9. PubMed ID: 335544
[No Abstract] [Full Text] [Related]
38. Advanced Hodgkin's disease. Management with chemotherapeutic agents.
Gellhorn A
JAMA; 1965 Jan; 191(4):315-6. PubMed ID: 5899748
[No Abstract] [Full Text] [Related]
39. Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
DeConti RC; Kaplan SR; Calabresi P
Blood; 1972 May; 39(5):602-9. PubMed ID: 5067305
[No Abstract] [Full Text] [Related]
40. Chemotherapy of the non-Hodgkin's lymphomas.
Pasmantier MW; Coleman M; Silver RT
Med Clin North Am; 1976 Sep; 60(5):1043-52. PubMed ID: 59842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
